---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-026533"
form_type: "8-K"
ticker: "CABR"
cik: "0002020737"
company_name: "Caring Brands, Inc."
filed_at: "2026-06-01T12:05:42+00:00"
generated_at: "2026-06-01T12:11:51.761434+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Caring Brands expands licensing deal for Photocil and Hair Enzyme Booster to 5-year term, new territories

## Summary
- Revised five-year licensing agreement effective May 21, 2026, expands territories to India (existing), LATAM, Russia, Australia, and New Zealand.
- SCPL's existing sublicense partners include Eris, Dr. Reddy's, Cipla, Dabur, Glenmark for Hair Enzyme Booster in multiple Asian and Middle Eastern markets.
- Photocil (commercialized as Photofirst by Eris) is a patented topical for vitiligo, psoriasis, and atopic dermatitis.
- Hair Enzyme Booster is a first-of-its-kind topical that increases SULT1A1 enzyme to convert Minoxidil into active form for hair growth.
- CEO Glynn Wilson stated the expanded agreement reflects confidence in SCPL and aims to improve revenue stream.

## SEC filing metadata
- accession: 0001493152-26-026533
- form_type: 8-K
- ticker: CABR
- cik: 0002020737
- company_name: Caring Brands, Inc.
- filed_at: 2026-06-01T12:05:42+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2020737/000149315226026533/0001493152-26-026533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2020737/000149315226026533/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-026533
- JSON: https://secwatch.observer/filing/0001493152-26-026533.json
- Plain text: https://secwatch.observer/filing/0001493152-26-026533.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.